About
4.26USD-0.03 -0.70%
Closed • Updated at 22:43 GMT+00:00Market Cap$346.75M
Volume569.5K
Beta0.40
RSI35.42
Gross Margin99.56%
Opus Genetics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
May 7 2026
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
May 4 2026
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
Apr 27 2026
Opus Genetics to Participate in Leading Medical Conferences in May 2026
Apr 10 2026
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Community Chat
Ask AI
Try asking
Translate